City Therapeutics

CTY · US

None of the tracked investors reported this stock. 13F covers US-listed securities only.

In the last 90 days insiders sold 0 times ($0) and bought 2 times on the open market.

Big investors holding this stock

Latest 13F of the 26 tracked investors. Common shares only.

None of the tracked investors reported this stock. 13F covers US-listed securities only.

5%+ holders (13D/13G)

SEC

Holder	Stake	Change	Filed
Arch Venture Fund Xii, L.P. Active	25.6%	New filing	10/26
Viking Global Investors Passive	7.0%	New filing	10/26
Invus Public Equities, L.P. Passive	8.1%	New filing	10/22

Holder

Stake

Change

Filed

Arch Venture Fund Xii, L.P.

Active

25.6%

New filing

10/26

Viking Global Investors

Passive

7.0%

New filing

10/26

Invus Public Equities, L.P.

Passive

8.1%

New filing

10/22

Insider trades (90 days)

SEC Form 4

Insider	Trade	Amount ($)
Arch Venture Partners Xii, LLC 10% owner · 10/19	Buy	3.1M
Robert Nelsen 10% owner · 10/19	Buy	3.1M

Insider

Trade

Amount ($)

Arch Venture Partners Xii, LLC

10% owner · 10/19

Buy

3.1M

Robert Nelsen

10% owner · 10/19

Buy

3.1M

Key points

Note: 0 open-market sales ($0) and 2 purchases in the last 90 days; 0 of the sales were under pre-arranged 10b5-1 plans.

Discussion

Loading…

Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.